Friday, Nov. 6, 2015, 72 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $473.82 to $10,527,076.00.

Highlighted Stocks Traded by Insiders:

American Financial Group (AFG) - FREE Research Report

Jacobs Terry S, who is Director at American Financial Group, sold 100 shares at $70.80 on Nov. 6, 2015. Following this transaction, the Director owned 2,046 shares meaning that the stake was reduced by 4.66% with the 100-share transaction.

The shares most recently traded at $70.62, down $0.18, or 0.26% since the insider transaction. Historical insider transactions for American Financial Group go as follows:

  • 4-Week # shares sold: 5,297
  • 12-Week # shares sold: 5,297
  • 24-Week # shares sold: 14,650

The average volume for American Financial Group has been 314,100 shares per day over the past 30 days. American Financial Group has a market cap of $6.2 billion and is part of the financial sector and insurance industry. Shares are up 17.56% year-to-date as of the close of trading on Friday.

American Financial Group, Inc., through its subsidiaries, provides property and casualty insurance products in the United States. The stock currently has a dividend yield of 1.58%. The company has a P/E ratio of 17.7. Currently, there are 3 analysts who rate American Financial Group a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AFG - FREE

TheStreet Quant Ratings

rates American Financial Group as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

American Financial Group Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Healthsouth (HLS) - FREE Research Report

Herman Joan E, who is Director at Healthsouth, bought 1,000 shares at $35.28 on Nov. 6, 2015. Following this transaction, the Director owned 13,590 shares meaning that the stake was boosted by 7.94% with the 1,000-share transaction.

The shares most recently traded at $34.98, down $0.30, or 0.85% since the insider transaction. Historical insider transactions for Healthsouth go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 106
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 106
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 106

The average volume for Healthsouth has been 815,200 shares per day over the past 30 days. Healthsouth has a market cap of $3.2 billion and is part of the health care sector and health services industry. Shares are down 7.59% year-to-date as of the close of trading on Friday.

HealthSouth Corporation owns and operates inpatient rehabilitation hospitals in the United States. The company provides specialized rehabilitative treatment on an inpatient and outpatient basis. The stock currently has a dividend yield of 2.62%. The company has a P/E ratio of 19.0. Currently, there are 6 analysts who rate Healthsouth a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HLS - FREE

TheStreet Quant Ratings

rates Healthsouth as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, good cash flow from operations and increase in net income. We feel its strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full

Healthsouth Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Avista (AVA) - FREE Research Report

Kensok James M, who is Vice President at Avista, sold 425 shares at $33.22 on Nov. 6, 2015. Following this transaction, the Vice President owned 9,871 shares meaning that the stake was reduced by 4.13% with the 425-share transaction.

The shares most recently traded at $32.89, down $0.33, or 0.99% since the insider transaction. Historical insider transactions for Avista go as follows:

  • 4-Week # shares sold: 16,720
  • 12-Week # shares sold: 24,220
  • 24-Week # shares sold: 24,220

The average volume for Avista has been 277,100 shares per day over the past 30 days. Avista has a market cap of $2.1 billion and is part of the utilities sector and utilities industry. Shares are down 6.68% year-to-date as of the close of trading on Friday.

Avista Corporation, an electric and natural gas utility company, generates, transmits, and distributes electricity; and distributes natural gas in the United States and Canada. It operates in two segments, Avista Utilities and Alaska Electric Light and Power Company. The stock currently has a dividend yield of 3.83%. The company has a P/E ratio of 17.8. Currently, there are no analysts who rate Avista a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AVA - FREE

TheStreet Quant Ratings

rates Avista as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, growth in earnings per share and increase in net income. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Avista Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.